Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery

Ítems similars

• Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
  per: Base, E, et al.
  Publicat: (2006)
• HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
  per: Bepperling, F, et al.
  Publicat: (1999)
• HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
  per: Bepperling, F, et al.
  Publicat: (1999)
• Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
  per: Ertmer, C, et al.
  Publicat: (2011)
• Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma
  per: Neff, ThA, et al.
  Publicat: (2001)